Exact Mass: 568.2015
Exact Mass Matches: 568.2015
Found 91 metabolites which its exact mass value is equals to given mass value 568.2015
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
rel-(1??,2??)-Di-(2,6-dimethoxy-4-hydroxy)-benzoyl-rel-(3??,4??)-diphenylcyclobutane|rel-1alpha,2beta-di-(2,6-dimethoxy-4-hydroxy)benzoyl-(3alpha,4beta)-diphenylcyclobutane
eriobioside|methyl (1S*,4aR*,7S*)-1-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylate
3-O-beta-D-(4-p-cumaryl)-Glukosid von Pterolacton A
Cys Phe His Tyr
Cys Phe Asn Trp
Cys Phe Trp Asn
Cys Phe Tyr His
Cys His Phe Tyr
Cys His Tyr Phe
Cys Asn Phe Trp
Cys Asn Trp Phe
Cys Trp Phe Asn
Cys Trp Asn Phe
Cys Tyr Phe His
Cys Tyr His Phe
Glu Glu Glu Tyr
Glu Glu Tyr Glu
Glu Tyr Glu Glu
Phe Cys His Tyr
Phe Cys Asn Trp
Phe Cys Trp Asn
Phe Cys Tyr His
Phe His Cys Tyr
Phe His Tyr Cys
Phe Asn Cys Trp
Phe Asn Trp Cys
Phe Trp Cys Asn
Phe Trp Asn Cys
Phe Tyr Cys His
Phe Tyr His Cys
His Cys Phe Tyr
His Cys Tyr Phe
His Phe Cys Tyr
His Phe Tyr Cys
His Tyr Cys Phe
His Tyr Phe Cys
Asn Cys Phe Trp
Asn Cys Trp Phe
Asn Phe Cys Trp
Asn Phe Trp Cys
Asn Trp Cys Phe
Asn Trp Phe Cys
Trp Cys Phe Asn
Trp Cys Asn Phe
Trp Phe Cys Asn
Trp Phe Asn Cys
Trp Asn Cys Phe
Trp Asn Phe Cys
Tyr Cys Phe His
Tyr Cys His Phe
Tyr Glu Glu Glu
Tyr Phe Cys His
Tyr Phe His Cys
Tyr His Cys Phe
Tyr His Phe Cys
Ponatinib hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163790 - Flt-3-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
(R)-4-oxide-2,6-bis[4-(4-methoxyphenyl)--8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
ND-646
ND-646 is an orally bioavailable and steric inhibitor of acetyl-CoA carboxylase (ACC) with IC50s of 3.5 nM and 4.1 nM for recombinant hACC1 and hACC2, respectively.